Intended for healthcare professionals


Reply from author of review

BMJ 1996; 312 doi: (Published 22 June 1996) Cite this as: BMJ 1996;312:1611
  1. John R Absher
  1. Assistant professor of neurology Bowman Gray School of Medicine, Winston-Salem, North Carolina, USA

    EDITOR,—Jammi N Rao and J D Middleton mention “deficiencies” of my review in Evidence-Based Medicine of the trial of interferon beta-1b. They raise two basic points that deserve a response. Firstly, they caution that my review was not “sufficiently critical of the evidence” and support this claim by noting the “almost diametrically opposite conclusions” reached by me and an anonymous reviewer. Secondly, they criticise “the approach taken by Evidence-Based Medicine” and “warn” readers who rely …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription